Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene

Hepatology

Volumn 31, Issue 3, 2000, Pages 606-614

  Mohr, Leonhard ^a,c   Shankara, Srinivas ^b   Yoon, Seung Kew ^a,d   Krohne, Tim U ^c   Geissler, Michael ^c   Roberts, Bruce ^b   Blum, Hubert E ^c   Wands, Jack R ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GENZYME CORPORATION   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

^d The Catholic University of Korea   (South Korea)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE PHOSPHATE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; PRODRUG; PURINE NUCLEOSIDE PHOSPHORYLASE; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVATION; DRUG SENSITIVITY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ESCHERICHIA COLI;

EID: 0033999780     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310310     Document Type: Article

References (20)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
2. Ince N, Wands JR. The increasing incidence of hepatocellular carcinoma. N Engl J Med 1999;340:798-799.
3. Wands JR, Blum HE. Primary hepatocellular carcinoma. N Engl J Med 1991;325:729-731.
4. Bruix J. Treatment of hepatocellular carcinoma. HEPATOLOGY 1997;25:259-262.
5. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
6. Trinchet JC, Beaugrand M. Treatment of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1997;27:756-765.
7. Kim JH, Chung JB, Park IS, Kim BS, Yoo NC, Choi JH, Roh JK, et al. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines. Yonsei Med J 1993;34:35-44.
8. Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991;338:1356-1359.
9. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-431.
10. Xu GW, Sun ZT, Forrester K, Wang XW, Coursen J, Harris CC. Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene. HEPATOLOGY 1996;24:1264-1268.
11. Ruiz J, Qian C, Prieto J. Gene therapy of liver tumors: principles and applications. Digestion 1998;59(Suppl 2):92-96.
12. Qian C, Bilbao R, Bruna O, Prieto J. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. HEPATOLOGY 1995;22:118-123.
13. Kuriyama S, Nakatani T, Masui K, Sakamoto T, Tominaga K, Yoshikawa M, Fukui H, et al. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. HEPATOLOGY 1995;22:1838-1846.
14. Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 1993;4:725-731.
15. Sorscher EJ, Peng S, Bebok Z, Allan PW, Bennett LL Jr, Parker WB. Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines. Gene Ther 1994;1:233-238.
16. Parker WB, King SA, Allan PW, Bennett LL, Jr., Secrist JAR, Montgomery JA, Gilbert KS, et al. In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase. Hum Gene Ther 1997;8:1637-1644.
17. Hughes BW, Wells AH, Bebok Z, Allan PW, Parker WB, Sorscher EJ. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res 1995;55:3339-3345.
18. Hughes BW, King SA, Allan PW, Parker WB, Sorscher EJ. Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase. J Biol Chem 1998;273:2322-2328.
19. Roberts RJ, Akusjaervi G, Alestroem P, Gelinas RE, Gingeras TR, Sciaky D, Petterson U. A consensus sequence for the adenovirus-2 genome. In: Doerfler W, ed. Adenovirus DNA. Boston: Martinus Nijhoff, 1986;1-51.
20. Rich DP, Couture LA, Cardoza LM, Guiggio VM, Armentano D, Espino PC, Hehir K, et al. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther 1993;4:461-476.